New research gives hope for women suffering from Leigh syndrome and other mitochondrial diseases.
Recently, a team of 146 scientists unraveled the genome of the tsetse fly, the vector of a lethal disease called sleeping sickness. With this new genetic information, many scientists have proposed innovative solutions to protect the 70 million people in sub-Saharan Africa who are affected by this disease.
A better understanding of neural interaction with fat tissue can lead to more targeted treatments for obesity.
Recent research on the worm C. elegans reveals a connection between the gene SKN-1, proline, and fat accumulation. In the future, miracle drugs may target these genes to prevent weight gain, even in the condition of a high-sugar diet.
Recently, the Nonhuman Rights Project fought for legal personhood for a 26 year-old chimpanzee named Tommy. The case relates to current research on primate genetics, cognition, and emotion.
Yale Researchers Leonard Kaczmarek and Christopher Pittenger are working on investigating rare genetic diseases through a combination of genetic sequencing, basic science research and clinical application.
Identical twins share exactly the same genome, and are usually raised under the same conditions during the early parts of their lives. Thus, it is not surprising that identical twins share strikingly similar physical features. However, twins often find themselves
Dr. Murat Gunel and colleagues at the Yale New Haven Children’s Hospital used advanced genetic technology to map out an 18-month-old girl’s genetic sequence, diagnose her with a rare liver cancer, and provide a cure that opens the door to treating cancer through the use of personalized medicine.
A recent study is pushing new frontiers in the field of synthetic biology. Scientists have been able to successfully recode the entire genome of an E. coli bacterium, opening up vast commercial applications for the future of polymers, drug delivery systems, and more.
Yale researchers Professor Mark Gerstein and Dr. Ekta Khurana have led an investigation into non-coding regions of DNA resulting in the identification of cancer triggers for further characterization. Their process can be generalized to uncover triggers for other diseases, and these triggers could be potential targets for therapeutics and precision medicine.